A pocket-sized device automates multiplexed point-of-care RNA testing for rapid screening of infectious pathogens

Bowen Shu,Ling Lin,Bin Wu,Enqi Huang,Yu Wang,Zhujun Li,Haoyan He,Xiuxia Lei,Banglao Xu,Dayu Liu
DOI: https://doi.org/10.1016/j.bios.2021.113145
IF: 12.545
2021-06-01
Biosensors and Bioelectronics
Abstract:Rapid screening of infectious pathogens at the point-of-care (POC) is ideally low-cost, portable, easy to use, and capable of multiplex detection with high sensitivity. However, satisfying all these features in a single device without compromise remains a challenging task. Here, we introduce an ultraportable, automated RNA amplification testing device that allows rapid screening of infectious pathogens from clinical samples. In this device, 3D-printed structural parts incorporated with off-the-shelf mechanic/electronic components are utilized to create an inexpensive and automated droplet manipulation platform. On this platform, a simple configuration that couples a linear displacement of the chip with a tunable magnet array allows parallel and versatile droplet operations, including mixing, splitting, transporting, and merging. By exploiting a multi-channel droplet array chip to preload necessary reagents in "water-in-oil" format, bacteria lysis, RNA extraction and amplification are seamlessly integrated and implemented by the combination of droplet operations. Furthermore, visual readout and geometrically-multiplexed quantitative detection are provided by an integrated wireless video camera-enabled wide-field fluorescence imaging. We demonstrated that this droplet-based device could have a shorter RNA extraction time (12 min) and lower detection limits for pathogenic RNA (approaching to 10<sup>2</sup> copies per reaction). We also verified its clinical applicability for the rapid screening of four sexually transmitted pathogens from urine specimens. Results show that the sample-to-answer assay could be completed in approximately 42 min, with 100% concordance with the laboratory-based molecular testing. The exhibiting features may render this microdevice an easily accessible POC molecular diagnostic platform for infectious disease, especially in resource-limited settings.
biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology
What problem does this paper attempt to address?
The paper aims to address the issue of rapid screening of infectious pathogens in Point-of-Care (POC) settings. Specifically, the authors have developed a portable, automated RNA detection device capable of rapid screening for multiple infectious pathogens in clinical samples. Existing POC diagnostic tests often fail to fully meet the following characteristics: sufficient sensitivity, multiplexing capability, necessary sample processing, portable and easy-to-use operating systems, and low cost. To address these issues, the research team proposed an integrated microfluidic device that combines the advantages of advanced nanomaterials, amplification chemistry, consumer electronics, 3D printing technology, and microfluidic technology to achieve highly sensitive, multiplexed, automated, and low-cost detection of infectious pathogens. Key features of the device include: - Construction of a low-cost, automated droplet operation platform using 3D printing technology and off-the-shelf mechanical/electronic components. - Simplified configuration allowing parallel and diverse droplet operations such as mixing, splitting, transferring, and merging. - Integrated wide-field fluorescence imaging supported by a wireless video camera, providing ultra-portable real-time fluorescence readout. - High-sensitivity pathogen detection using an isothermal amplification method targeting 16S rRNA, leveraging the natural abundance of ribosomal RNA (rRNA) in bacterial cells. Through these innovations, the research team demonstrated that the device could reduce RNA extraction time to 12 minutes and achieve a detection limit for pathogen RNA close to 10^2 copies per reaction. Additionally, the device showed 100% consistency in the rapid screening of four sexually transmitted pathogens in clinical settings, proving its potential application value in resource-limited environments.